Drug Type Tetraspecific antibody |
Synonyms Therapeutics LASER (OPKO) |
Target |
Mechanism CD19 modulators(B-lymphocyte antigen CD19 modulators), CD20 modulators(B-lymphocyte antigen CD20 modulators), CD28 modulators(T-cell-specific surface glycoprotein CD28 modulators) + [1] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Modex Therapeutics, Inc.Startup |
Active Organization Modex Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
B-Cell Lymphoma | Preclinical | US | Modex Therapeutics, Inc.Startup | 09 Mar 2023 |
Leukemia | Preclinical | US | Modex Therapeutics, Inc.Startup | 09 Mar 2023 |